Meet Hiro Life Sciences: Your Trusted AI Assistant for Accelerated Drug Discovery  

In the fast-paced world of biopharmaceutical research and development, accelerated access to real-time data and streamlined communication is imperative.  

AI is revolutionizing drug discovery by providing rapid access to vast and complex datasets, enabling researchers to quickly uncover valuable insights and connections that would be otherwise difficult to observe. By automating routine tasks, enabling advanced analytics, and streamlining workflows, AI is poised to make the entire R&D process significantly more efficient.  

Generative AI, in particular, is estimated to create $60-110 billion annually in economic value for the pharmaceutical industry due to its potential to scale productivity by accelerating the identification, development, approval, and marketing of new drugs. 

Our mission at Patsnap is to transform the way the world innovates. With the launch of Hiro Life Sciences (LS), we’re seamlessly integrating generative AI into the R&D process, bridging the gap between AI and drug discovery.  

Read on to learn how Hiro LS is democratizing access to high-quality data to accelerate drug discovery and development. 

The Intersection of LLMs with Pharma 

While general Large Language Models (LLMs) like GPT-4 exhibit remarkable capabilities in understanding and generating human-like text across a wide range of topics, they often fall short when tasked with domain-specific knowledge. This limitation becomes particularly evident in specialized fields such as pharmaceuticals, where nuanced understanding of biomedical terminology, drug interactions, and regulatory frameworks is critical.  

A new LLM trained specifically in pharmaceutical and scientific data promises to bridge this gap by leveraging a deep understanding of industry-specific language and context to enhance daily R&D tasks. With the ability to interpret complex biomedical topics and accurately generate domain-specific content, an LLM built to offer precise insights and solutions tailored to the pharmaceutical sector aims to advance healthcare innovation and efficiency.   

Hiro Life Sciences – Powering Drug Research with AI  

Hiro LS is the ultimate AI assistant enabling you to accelerate drug research by harnessing the power of generative AI.  Built for biopharma professionals and offered as both a standalone solution and an integrated in-product assistant, Hiro LS accelerates productivity through every stage of the drug development pipeline by equipping users with an intuitive and secure chatbot that facilitates 360^o learning, summarizing, idea-sharing, and deep exploration of the biopharmaceutical landscape. 

Whether you’re developing a new drug, researching competitor pipelines, conducting clinical research, or taking a drug to market, Hiro LS gives back meaningful time in your day by enhancing research efficiency across the whole development pipeline. Try asking questions related to:  

Drug development: 

Competitor pipelines: 

Clinical development:  

Drug policy: 

An AI Assistant Built for Biopharma  

Teams can effortlessly chat with Hiro LS on the go, enabling faster, more intuitive searches and significantly boosting R&D efficiency. In contrast, conventional search tools fall short in understanding complex scientific queries due to their reliance on exact keyword matches and lack of interactive and summarization capabilities, this slowing down the research process. Similarly, general-purpose LLMs that are trained on broad datasets covering a wide range of topics lack the specificity and depth required for scientific accuracy. 

Designed for drug research, Hiro LS draws from billions of data points across Patsnap’s robust ecosystem of life science intelligence to provide instant, actionable insights pertaining to new scientific research, drug pipelines, clinical progress, regulatory policy, market insights, and more.  

PharmaGPT, Patsnap’s own pharma-trained LLM, sits at the core of Hiro LS. Trained on both proprietary and specialized scientific datasets, including peer-reviewed articles, patents, drug data, clinical trials, experimental data, and more, PharmaGPT applies its robust knowledge base to accurately interpret complex biomedical and scientific queries, while integrating advanced techniques like retrieval-augmented generation (RAG) and reinforcement learning with human feedback (RLHF) to continuously improve the accuracy of its responses and relevance in real-world applications. 

In the highly regulated biopharma industry where transparency and security are essential, Hiro LS consistently delivers reliable, evidence-based insights through AI technology built on: 

• Accuracy: Hiro LS leverages Patsnap’s deep ecosystem of proprietary biopharma intelligence curated by AI and human domain experts, ensuring that search results are precise and reliable. 

• Transparency: Results are connected to their underlying sources to ensure they’re both explainable and reproducible, and users understand how results are generated. 

• Connectivity: PharmaGPT can be integrated into private enterprise data systems through APIs to enhance connectivity of their disparate systems and improve the efficiency and scalability of their existing workflows. 

• Security: Users can confidently converse with Hiro LS knowing that their data is never used to train the LLM. 

Search, Explore, and Take Action with Hiro LS  

Hiro LS redefines the way biopharma professionals navigate the rapidly evolving landscape by transforming vast datasets into actionable insights with speed and precision. Combining a powerful, intuitive interface with seamless integration into Patsnap’s Life Science intelligence solutions, Hiro LS sets a new benchmark for the fusion of AI with biopharma R&D. Designed to deliver fast, real-time answers to real-world challenges, it supports every stage of the drug development pipeline, empowering teams to innovate smarter, faster, and with greater confidence. 

With features like visual chart generation, document uploads, and shareable links, Hiro LS bridges the gap between data and discovery to fuel innovation and R&D across entire organizations. From a single search, you can:  

• Research: Chat with Hiro LS on a wide range of pharma and biomedical topics and get detailed, comprehensive summaries and analyses in a matter of seconds. 

• Analyze: Generate visual charts to power your analysis and export them for offline reporting. 

• Connect: Gain insights derived from billions of data points and connect directly to their sources, including proprietary data from Patsnap’s pharmaceutical, biosequence, and chemical structure intelligence platforms.  

• Upload: Attach and upload key documents to customize your search with more specificity. 

• Share: Share key insights and their sources by creating shareable links to your conversations with Hiro LS to collaborate more seamlessly.  

• Deep Explore: Fuel your R&D by transforming complex data into powerful, in-depth research reports for a wide range of biopharma topics. 

Accelerate your Drug Development Pipeline  

With the depth of domain knowledge provided by Patsnap’s pharma-trained LLM, Hiro LS fortifies your research workflows by unlocking the full potential of scientific data and boosting productivity at every stage of the pipeline. From early-stage research to clinical trials and regulatory submissions, Hiro LS is set to enhance communication and collaboration among biopharma teams to accelerate the development of new therapies and treatments. 

Supercharge your drug discovery with an AI chatbot built for biopharma. Try Hiro LS for free today!